463-73-0 Usage
General Description
Chlorocarbonic acid, also known as chloroformic acid, is a chemical compound with the formula HCOCl. It is a colorless, corrosive liquid with a pungent odor and is highly reactive. It is produced by the reaction of phosgene with water or by the reaction of chloroform with sodium hydroxide. Chlorocarbonic acid is primarily used as an intermediate in the production of various organic compounds, including pharmaceuticals, pesticides, and herbicides. It is also used in the synthesis of esters, which are important in the production of perfumes, flavorings, and plasticizers. Due to its corrosive and toxic nature, chlorocarbonic acid poses health and environmental risks and should be handled with caution.
Check Digit Verification of cas no
The CAS Registry Mumber 463-73-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,6 and 3 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 463-73:
(5*4)+(4*6)+(3*3)+(2*7)+(1*3)=70
70 % 10 = 0
So 463-73-0 is a valid CAS Registry Number.
InChI:InChI=1/CHClO2/c2-1(3)4/h(H,3,4)
463-73-0Relevant articles and documents
Photolabile Compound and Substrate for Oligomer Probe Array with the Same
-
, (2008/06/13)
Provided is a substrate for an oligomer probe array to which a photolabile material having an acetylene derivative is directly attached or attached via a linker.
Method of treating cancer using FPT inhibitors and antineoplastic agents
-
, (2008/06/13)
Disclosed is a method of treating cancer in a patient in need of such treatment comprising administering a therapeutically effective amount of an FPT inhibitor and therapeutically effective amounts of one or more antineoplastic agents. Methods of treating non small cell lung cancer, squamous cell cancer of the head and neck, CML, AML, non-Hodgkin's lymphoma and multiple myeloma are disclosed.
3-Unsubstituted-3-cephem compounds
-
, (2008/06/13)
Antibacterial compounds represented by the following formula including their pharmaceutically acceptable salts and esters; process for preparing them; pharmaceutical preparation comprising them; and method for combating infections by administering them: S
